Skip to content

The effect of Vitamin B6 on cognitive function in patients with heart failure: A randomized controlled trial

The effect of Vitamin B6 on cognitive function in patients with heart failure: A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103561
Enrollment
Unknown
Registered
2025-05-30
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

Intervention group:Vitamin B6, 20mg each time, twice a day

Sponsors

Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1.Clinically diagnosed as patient with HF; 2.Aged for 18-74 years old; 3.NYHA class ?-?;

Exclusion criteria

Exclusion criteria: 1. Smokers and alcoholics; 2. Those who took or injected VB6 3 months before admission; 3. Patients who are taking drugs that affect VB6 absorption, including anti-epileptic drugs, anti-tuberculosis drugs, contraceptives and estrogen drugs; 4. Those with VB6 allergy; 5. Those who are receiving cognitive training or participating in other interventional investigators; 6. Combined with neurological diseases, such as Alzheimer's disease, Parkinson's disease, etc.; 7. Combined with digestive system diseases, such as inflammatory bowel disease, ulcerative colitis, etc.; 8. Combined psychiatric diseases, such as depression, schizophrenia, etc.; 9. History of cancer; 10. Combined with autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, etc.; 11. Co-existing infectious diseases, such as AIDS, tuberculosis, etc.; 12. Those who are unable to cooperate with the completion of cognitive assessment such as hearing and hearing impairment; 13. Lactating or pregnant women;

Design outcomes

Primary

MeasureTime frame
Cognitive function;

Secondary

MeasureTime frame
VB6 level;Inflammation level;Tryptophan level;

Countries

China

Contacts

Public ContactLin Yanjuan/Li Qianzhen

Fujian Medical University Union Hospital

doctorlqz@163.com+86 591 8621 8336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026